A biopharmaceutical company focused on novel immunotherapy agents for cancer and inflammatory diseases.

Products


Overview

CNDO–201

CNDO-201 is Coronado Biosciences' designation for our immunomodulator, Trichuris suis ova (TSO), the microscopic eggs of a parasitic helminth also known as the pig whipworm. The use of TSO as a therapeutic immunomodulator is based on the "hygiene hypothesis" and numerous animal and human studies. TSO was chosen as the biological agent of choice because it is not a human pathogen and is spontaneously eliminated from the body within several weeks after dosing. Multiple investigator-sponsored clinical trials of TSO for the treatment of Crohn's disease, ulcerative colitis and multiple sclerosis have been completed in which TSO demonstrated benefit with regard to accepted outcome measurements of remission of disease and was shown to be well tolerated.

CNDO–109

CNDO-109 is Coronado Biosciences' designation for a proprietary membrane lysate that has been shown to activate Natural Killer (NK) cells. Natural Killer cells are part of the innate immune system found in every individual. They are special lymphocytes that are part of our first line of defense against cancer cells and virus-infected cells. When activated, NK cells have the ability to differentiate between normal cells and cancer cells, and kill cancer cells by granzyme mediated lysis, a biochemical process whereby the NK cells directly kill the target cancer cells by destroying their cell membranes and structures.

15 New England Executive Park
Burlington, MA 01803
Phone: 781-238-6621
Fax: 781-459-7788
Email: info@coronadobio.com

© Copyright 2011 Coronado Biosciences  |  Privacy Policy  |  Site Map

 Created by Tidal Media Group